Asakura Keiichi, Hayashi Seiji, Ojima Atsuko, Taniguchi Tomohiko, Miyamoto Norimasa, Nakamori Chiaki, Nagasawa Chiho, Kitamura Tetsuo, Osada Tomoharu, Honda Yayoi, Kasai Chieko, Ando Hiroyuki, Kanda Yasunari, Sekino Yuko, Sawada Kohei
Japanese Safety Pharmacology Society (JSPS), 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan; Japan iPS Cardiac Safety Assessment (JiCSA), 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan; Non-Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA), 2-3-11 Nihonbashi-Honcho, Chuo-ku, Tokyo 103-0023, Japan; Consortium for Safety Assessment using Human iPS Cells (CSAHi), Japan; Nippon Shinyaku Co., Ltd., 14, Nishinosho-Monguchi-cho, Kisshoin, Minami-ku, Kyoto 601-8550, Japan. Electronic address: http://www.j-sps.org/
Japanese Safety Pharmacology Society (JSPS), 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan; Japan iPS Cardiac Safety Assessment (JiCSA), 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan; Nippon Shinyaku Co., Ltd., 14, Nishinosho-Monguchi-cho, Kisshoin, Minami-ku, Kyoto 601-8550, Japan. Electronic address: http://www.j-sps.org/
J Pharmacol Toxicol Methods. 2015 Sep-Oct;75:17-26. doi: 10.1016/j.vascn.2015.04.002. Epub 2015 Apr 22.
Multi-electrode array (MEA) systems and human induced pluripotent stem (iPS) cell-derived cardiomyocytes are frequently used to characterize the electrophysiological effects of drug candidates for the prediction of QT prolongation and proarrhythmic potential. However, the optimal experimental conditions for obtaining reliable experimental data, such as high-pass filter (HPF) frequency and cell plating density, remain to be determined.
Extracellular field potentials (FPs) were recorded from iPS cell-derived cardiomyocyte sheets by using the MED64 and MEA2100 multi-electrode array systems. Effects of HPF frequency (0.1 or 1Hz) on FP duration (FPD) were assessed in the presence and absence of moxifloxacin, terfenadine, and aspirin. The influence of cell density on FP characteristics recorded through a 0.1-Hz HPF was examined. The relationship between FP and action potential (AP) was elucidated by simultaneous recording of FP and AP using a membrane potential dye.
Many of the FP waveforms recorded through a 1-Hz HPF were markedly deformed and appeared differentiated compared with those recorded through a 0.1-Hz HPF. The concentration-response curves for FPD in the presence of terfenadine reached a steady state at concentrations of 0.1 and 0.3μM when a 0.1-Hz HPF was used. In contrast, FPD decreased at a concentration of 0.3μM with a characteristic bell-shaped concentration-response curve when a 1-Hz HPF was used. The amplitude of the first and second peaks in the FP waveform increased with increasing cell plating density. The second peak of the FP waveform roughly coincided with AP signal at 50% repolarization, and the negative deflection at the second peak of the FP waveform in the presence of E-4031 corresponded to early afterdepolarization and triggered activity.
FP can be used to assess the QT prolongation and proarrhythmic potential of drug candidates; however, experimental conditions such as HPF frequency are important for obtaining reliable data.
多电极阵列(MEA)系统和人诱导多能干细胞(iPS)衍生的心肌细胞常用于表征候选药物的电生理效应,以预测QT间期延长和致心律失常潜力。然而,获得可靠实验数据的最佳实验条件,如高通滤波器(HPF)频率和细胞铺板密度,仍有待确定。
使用MED64和MEA2100多电极阵列系统从iPS细胞衍生的心肌细胞片记录细胞外场电位(FPs)。在存在和不存在莫西沙星、特非那定和阿司匹林的情况下,评估HPF频率(0.1或1Hz)对FP持续时间(FPD)的影响。研究了细胞密度对通过0.1Hz HPF记录的FP特征的影响。通过使用膜电位染料同时记录FP和动作电位(AP),阐明了FP与AP之间的关系。
与通过0.1Hz HPF记录的波形相比,通过1Hz HPF记录的许多FP波形明显变形且出现分化。当使用0.1Hz HPF时,在存在特非那定的情况下,FPD的浓度 - 反应曲线在0.1和0.3μM浓度下达到稳态。相比之下,当使用1Hz HPF时,FPD在0.3μM浓度下下降,具有特征性的钟形浓度 - 反应曲线。FP波形中第一和第二峰的幅度随着细胞铺板密度的增加而增加。FP波形的第二个峰大致与50%复极化时的AP信号重合,并且在存在E - 4031的情况下,FP波形第二个峰处的负向偏转对应于早期后去极化和触发活动。
FP可用于评估候选药物的QT间期延长和致心律失常潜力;然而,诸如HPF频率等实验条件对于获得可靠数据很重要。